Bridgeway Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-175,200
| Closed | -$1.74M | – | 1493 |
|
|
2023
Q1 | $1.74M | Hold |
175,200
| – | – | 0.05% | 577 |
|
|
2022
Q4 | $1.75M | Hold |
175,200
| – | – | 0.05% | 589 |
|
|
2022
Q3 | $965K | Sell |
175,200
-58,000
| -25% | -$322K | 0.03% | 748 |
|
|
2022
Q2 | $851K | Buy |
233,200
+98,800
| +74% | +$467K | 0.02% | 761 |
|
|
2022
Q1 | $813K | Sell |
134,400
-30,400
| -18% | -$185K | 0.02% | 827 |
|
|
2021
Q4 | $1.39M | Sell |
164,800
-23,500
| -12% | -$205K | 0.03% | 718 |
|
|
2021
Q3 | $1.71M | Buy |
188,300
+37,200
| +25% | +$320K | 0.03% | 683 |
|
|
2021
Q2 | $1.22M | Buy |
151,100
+16,700
| +12% | +$115K | 0.02% | 788 |
|
|
2021
Q1 | $741K | Buy |
134,400
+56,200
| +72% | +$278K | 0.01% | 969 |
|
|
2020
Q4 | $266K | Sell |
78,200
-40,500
| -34% | -$107K | 0.01% | 1147 |
|
|
2020
Q3 | $201K | Hold |
118,700
| – | – | ﹤0.01% | 1175 |
|
|
2020
Q2 | $192K | Hold |
118,700
| – | – | ﹤0.01% | 1158 |
|
|
2020
Q1 | $228K | Buy |
118,700
+15,000
| +14% | +$39.4K | 0.01% | 1020 |
|
|
2019
Q4 | $296K | Hold |
103,700
| – | – | ﹤0.01% | 1121 |
|
|
2019
Q3 | $345K | Buy |
103,700
+23,700
| +30% | +$75.1K | ﹤0.01% | 1064 |
|
|
2019
Q2 | $260K | Buy |
+80,000
| New | +$285K | ﹤0.01% | 1129 |
|
|
2019
Q1 | – | Sell |
-79,000
| Closed | -$273K | – | 1419 |
|
|
2018
Q4 | $273K | Hold |
79,000
| – | – | ﹤0.01% | 1157 |
|
|
2018
Q3 | $566K | Hold |
79,000
| – | – | 0.01% | 1107 |
|
|
2018
Q2 | $551K | Hold |
79,000
| – | – | 0.01% | 1102 |
|
|
2018
Q1 | $486K | Hold |
79,000
| – | – | 0.01% | 1101 |
|
|
2017
Q4 | $442K | Sell |
79,000
-20,000
| -20% | -$91.1K | ﹤0.01% | 1132 |
|
|
2017
Q3 | $463K | Buy |
99,000
+79,000
| +395% | +$417K | 0.01% | 1115 |
|
|
2017
Q2 | $160K | Buy |
20,000
+5,000
| +33% | +$40.8K | ﹤0.01% | 1322 |
|
|
2017
Q1 | $190K | Buy |
+15,000
| New | +$191K | ﹤0.01% | 1290 |
|
Bridgeway Capital Management's APEN Position: Q2 2023 in Review
Bridgeway Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 175,200 shares — an estimated $1.74M sold.
Bridgeway Capital Management first reported a position in APEN in Q1 2017 and held it in 24 quarters. The position peaked at $1.75M in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Bridgeway Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Bridgeway Capital Management sold 175,200 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $1.74M.
- Bridgeway Capital Management first reported a position in Apollo Endosurgery, Inc. in Q1 2017 and held it in 24 quarters.
- Bridgeway Capital Management's Apollo Endosurgery, Inc. position peaked at $1.75M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.